Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


    Mental health

    The latest learning and CPD content on mental health. Under ‘Other resources’ you will find all our other content related to mental health.

    CPD and Learning

    Diabetes: mental health considerations in adults

    Diabetes: mental health considerations in adults Subscription

    11 AUG 2020By ,

    Pharmacists can contribute to the psychological and emotional wellbeing of people living with diabetes by helping to identify those who have mental wellbeing needs, optimising treatment and minimising risk factors.

    Case-based learning: anxiety disorders

    Case-based learning: anxiety disordersSubscription

    1 MAY 2020By

    There are many types of anxiety disorders with varying levels of severity. Pharmacists should know the treatment options that are available and how to support patients. 

    Olanzapine 5mg tablet pack

    Schizophrenia case studies: putting theory into practiceSubscription

    16 APR 2020By

    This article considers how patients with schizophrenia should be managed when their condition or treatment changes.

    Pack of amisulpride tablets

    Schizophrenia: recognition and management Subscription

    25 FEB 2020By

    Common medicines used to manage schizophrenia have many side effects that can cause significant morbidity. Regular monitoring and support can ensure patients improve outcomes.

    Exercise class

    Encouraging self-care and positive lifestyle changes in patients with depressionSubscription

    19 FEB 2020By

    Non-pharmacological interventions, such as maintaining good sleep hygiene and a healthy diet, can help improve, resolve or prevent depression.

    Case based learning postnatal depression

    Case-based learning: postnatal depressionSubscription

    17 JAN 2020By

    Appropriate early recognition and timely treatment of postnatal depression is essential if patients are to make a full recovery.

    Postnatal depression: recognition and diagnosis

    Postnatal depression: recognition and diagnosisSubscription

    7 JAN 2020By

    Pharmacists are likely to encounter patients affected by postnatal depression; therefore, the ability to identify signs of this under-recognised disorder is essential for appropriate and prompt referral for help and support.

    body dysmorphic disorder

    Recognising and managing body dysmorphic disorderSubscription

    10 SEP 2019By , ,

    A range of symptoms can indicate potential body dysmorphic disorder. Pharmacists should know how to have conversations about this condition and provide advice about the available treatments.

    Other resources

    Cognitive behavioural therapy: how does it work?

    Cognitive behavioural therapy: breaking the cycleSubscription

    27 FEB 2020By ,

    The most common alternative to pharmacological treatment offered to patients with depression and anxiety by the NHS is cognitive behavioural therapy, or ‘CBT’. This guide details how it works.

    cannabis marijuana medical bedrocan

    Poor evidence available on cannabinoids in mental health conditionsSubscription

    4 DEC 2019

    There is a lack of high-quality evidence supporting the use of cannabinoids in the treatment of mental disorders, the authors of a meta-analysis published in the Lancet Psychiatry have concluded.

    Cognitive cannabis

    Cognitive cannabis: the emerging evidence for treating mental health problemsSubscription

    31 OCT 2019By

    One year since UK law changed to enable medical cannabis to be prescribed, researchers are exploring the drug’s potential for treating post-traumatic stress disorder, schizophrenia and attention deficit hyperactivity disorder.

    Sertraline blister pack

    Sertraline may reduce anxiety more quickly than depressive symptomsSubscription

    24 OCT 2019

    Sertraline is unlikely to reduce depressive symptoms within six weeks, according to findings from a randomised controlled trial in The Lancet Psychiatry.

    Fluoxetine bottle

    NICE guidance linked with rising antidepressant use in childrenSubscription

    3 SEP 2019

    National Institute for Health and Care Excellence guidelines from 2005 may have inadvertently led to increased antidepressant prescribing in children aged under 18 years.

    Pill blister packs

    Antidepressants in the treatment of major depression: a changing landscape for clinical decision makingSubscription

    2 APR 2019By

    With publication of the update to the National Institute of Health and Care Excellence depression guideline postponed until late 2019, this article aims to examine the findings of the Cipriani et al. meta-analysis in the wider context of the management of depression in the UK.

    A person researching suicide on the website

    What could UK pharmacy teams learn about suicide prevention from North America?Subscription

    5 MAR 2019By

    From the perspective of their clinical and holistic role, and restriction of access to means, there are opportunities to involve pharmacy teams in suicide prevention. This article examines the published evidence-base and the success of ongoing programmes and initiatives in the United States and Canada to produce a set of recommendations for the benefit of UK practice on the opportunities community pharmacy teams have to raise awareness and help prevent suicide and self-harm.

    Hospital corridor

    Statins and metformin could be used to treat serious mental illnessSubscription

    30 JAN 2019

    Existing medicines for physical conditions such as diabetes and hypertension could be used to treat serious mental illness, concluded the authors of a recent study in JAMA Psychiatry.


    Pharmacists and pharmacy technicians can find guidance from The Pharmaceutical Journal on completing the relevant records to meet the General Pharmaceutical Council requirements, as well as support on the scope of activity that could be included in these records here.